Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NBTY seals Leiner deal

This article was originally published in The Tan Sheet

Executive Summary

Nutritional supplement manufacturer and marketer NBTY announced July 14 it completed its purchase of substantially all Leiner Health Products' assets for $371 million (1"The Tan Sheet" June 16, 2008, p. 3)...

You may also be interested in...



NBTY Forced To Hike Prices By Leiner Integration Costs, Shrinking Margins

NBTY plans to raise prices for its Nature's Bounty brand dietary supplements in January 2009 following a 63.8 percent decrease in net income in its latest earnings period

NBTY Leiner Buy Intensifies Supplement Ingredient Competition

The dietary supplement ingredient supply market is set to become more competitive with NBTY's planned acquisition of Leiner Health Products

Health And Wellness Weekly Trademarks Review: 9 August

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS101893

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel